SGLT2

Beyond A1C: Diabetes Treatments That Also Address Heart and Kidney Risk

By LaborForce Media / 11/22/2026

Certain GLP-1 and SGLT2 medicines offer benefits beyond blood sugar control—expanding the conversation about long-term health for working people and their families. LaborForce Media | Innovation Corner | Diabetes Awareness Month For years, many diabetes conversations have centered on A1C, a measure of average blood glucose over approximately three months. That number remains important. But…